Literature DB >> 387045

Sucralfate: antipeptic, antiulcer activities and antagonism of gastric emptying.

L E Borella, K Seethaler, W Lippmann.   

Abstract

The antiulcerogenic and antipeptic activities of sucralfate (Ulcerlmin), a basic aluminum sucrose sulfate complex, were investigated. In rats, sucralfate inhibited the formation of ulcers induced by pyloric ligation, indometacin and cysteamine. In doses antagonizing forestomach ulcer formation, sucralfate increased the pH of the gastric juice in a dose-related manner. In vitro, at pH 1.9, sucralfate inhibited rat, dog and hog pepsin in a concentration-related manner and also the peptic activity in human gastric juice. Sucralfate may act as an inhibitor of pepsin by precipitating the enzyme or by binding with it reversibly. The antipeptic activity appears to be directly related to the amount of sucralfate in suspension rather than that in solution. In the gastrointestinal tract, the basic nature of sucralfate may enhance the antipeptic activity of the sucralfate molecule. In rats, sucralfate decreases the rate of gastric emptying.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 387045

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  6 in total

Review 1.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

2.  Endoscopic evaluation of the effect of sucralfate therapy and other clinical parameters on the recurrence rate of gastric ulcers.

Authors:  T Miyake; J Ariyoshi; T Suzaki; M Oishi; M Sakai; S Ueda
Journal:  Dig Dis Sci       Date:  1980-01       Impact factor: 3.199

Review 3.  Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

4.  In vivo interaction of ketoconazole and sucralfate in healthy volunteers.

Authors:  P L Carver; R R Berardi; M J Knapp; J M Rider; C A Kauffman; S F Bradley; M Atassi
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

5.  Cimetidine absorption in humans during sucralfate coadministration.

Authors:  R D'Angio; M Mayersohn; K A Conrad; M Bliss
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

6.  Acid suppression therapy and allergic reactions.

Authors:  Eva Untersmayr
Journal:  Allergo J Int       Date:  2015-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.